aiqbench analysis
The Novo Nordisk Foundation's investment in a 5,300 m² fabrication facility marks a strategic shift from pure research to industrial-scale manufacturing for European quantum chips. By combining nanofabrication with ultra-high vacuum capabilities, this project directly addresses the critical bottleneck of scaling quantum technology beyond the lab to build fault-tolerant systems by 2034. This development strengthens Europe's technological sovereignty and diversifies funding sources beyond traditional public grants and venture capital.
Novo Nordisk Foundation funds Copenhagen quantum facility

The Novo Nordisk Foundation and Quantum Foundry Copenhagen will establish a new 5,300 m² quantum chip fabrication facility in Copenhagen, strengthening Europe’s ability to design, manufacture, and scale next-generation quantum chips. This facility will develop advanced manufacturing equipment, supporting Europe’s position in the global quantum landscape and its ambition to turn scientific excellence into industrial capability.
A new 5,300 m² quantum chip fabrication facility will soon be established in Copenhagen, signaling substantial investment in European quantum manufacturing. Owned by the Novo Nordisk Foundation, Quantum Foundry Copenhagen will uniquely combine nanofabrication labs with ultra-high vacuum manufacturing to offer wafer fabrication for quantum technology vendors. “Europe’s quantum ambitions depend on our ability to…
Excerpt shown under the publisher's RSS terms · 55 words · full text and figures are on the publisher's site
Related coverage

BioInnovation Institute Selects 17 European Startups for Funding and Support
The Quantum Insider · Sep 16, 2026

BII aims to support 30 startups a year with new funding
Quantum Zeitgeist · Sep 17, 2026

New Copenhagen facility to strengthen Europe quantum manufacturing capabilities
manilatimes.net · Sep 4, 2026

Quantum Foundry Copenhagen Plans 5,300-Square-Meter Chip Facility
The Quantum Insider · Sep 4, 2026